Top

Published in:

Open Access 01-12-2018 | Research

Do site and type of metastasis in breast cancer show a changing pattern with increased age? A cross comparison of clinicopathological characteristics between age groups

Authors: Majid Akrami, Afrooz Sepahdar, Peyman Arasteh, Sedigheh Tahmasebi, Vahid Zangouri, Azam Askari, Babak Pezeshki, Abdolrasoul Talei

Published in: World Journal of Surgical Oncology | Issue 1/2018

Abstract

Background

In here, we evaluated pattern of metastasis and cross-compared clinicopathological features between different age groups with breast cancer (BC).

Methods

This study was conducted in the Shiraz Breast Cancer Registry (largest BC registry in Iran). Patients were classified as < 30 years old (group 1), 30–60 years old (group 2), and > 60 years old (group 3). The three age groups were compared regarding clinical and baseline characteristics.

Results

Overall, 564 individuals entered group 1, 4519 group 2, and 670 group 3.

Group 1 had lower rates of tumor necrosis (p < 0.001), higher lymphatic or vascular invasion (p = 0.002), estrogen receptor-negative individuals, and HER2-positive individuals (p ≤ 0.001).

Younger groups had more stage 3 BC (31.1, 25.6, and 19.7% for groups 1, 2, and 3, respectively) (p = 0.016), grade 3 BC (27.4, 20.6, and 16.5% for groups 1, 2, and 3, respectively) (p = 0.001), and grade 3 nucleus (43.1, 34.5, and 27.6% for groups 1, 2, and 3, respectively) (p < 0.001).

Group 1 had higher rates of regional metastasis (4.7 vs. 1.5 and 2.1% for groups 2 and 3, respectively). Younger individuals had higher rates of brain metastasis (13.3, 5.4, and 1.1% for groups 1, 2, and 3, respectively). Moreover, those > 60 years old had more lung metastasis (33 vs. 12.6 and 6.7% for groups 2 and 1, respectively) (p < 0.001).

Younger groups had more < 5-year recurrence (16.3, 11.7, and 8.9%, for groups 1, 2, and 3, respectively) (p = 0.023).

Conclusion

Pattern and site of recurrence changes according to age in BC. This brings up the question whether age is an independent predictor of organ of metastasis or is site of metastasis the result of other clinicopathological determinants which differ between age groups.

Anders CK, Johnson R, Litton J, Phillips M, Bleyer A. Breast cancer before age 40 years. Semin Oncol. 2009;36(3):237–49.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. https://doi.org/10.1002/ijc.29210.

Muss HB. Coming of age: breast cancer in seniors. Oncologist. 2010;15(Supplement 5):57–65.CrossRefPubMed

Anders CK, Hsu DS, Broadwater G, Acharya CR, Foekens JA, Zhang Y, Wang Y, Marcom PK, Marks JR, Febbo PG. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol. 2008;26(20):3324–30.CrossRefPubMed

Sabiani L, Houvenaeghel G, Heinemann M, Reyal F, Classe JM, Cohen M, Garbay JR, Giard S, Charitansky H, Chopin N. Breast cancer in young women: pathologic features and molecular phenotype. Breast. 2016;29:109–16.CrossRefPubMed

Pappo I, Karni T, Sandbank J, Dinur I, Sella A, Stahl-Kent V, Wasserman I, Halevy A. Breast cancer in the elderly: histological, hormonal and surgical characteristics. Breast. 2007;16(1):60–7.CrossRefPubMed

Malik MK, Tartter PI, Belfer R. Undertreated breast cancer in the elderly. J Cancer Epidemiol. 2013;2013:7.

El Saghir NS, Seoud M, Khalil MK, Charafeddine M, Salem ZK, Geara FB, Shamseddine AI. Effects of young age at presentation on survival in breast cancer. BMC Cancer. 2006;6(1):194.CrossRefPubMedPubMedCentral

Gabriel CA, Domchek SM. Breast cancer in young women. Breast Cancer Res. 2010;12(5):212.CrossRefPubMedPubMedCentral

10.

Rosenberg SM, Partridge AH. Management of breast cancer in very young women. Breast. 2015;24(Suppl 2):S154–8. https://doi.org/10.1016/j.breast.2015.07.036.CrossRefPubMed

11.

Gal O, Ishai Y, Sulkes A, Shochat T, Yerushalmi R. Early breast Cancer in the elderly: characteristics, therapy, and long-term outcome. Oncology. 2017; https://doi.org/10.1159/000480087.

12.

Nuzhat A, Abouzaid LZ. Female breast cancer in different age groups: clincopathological features and treatment strategies. Int J Commun Med Public Health. 2017;4(5):1399–405.CrossRef

13.

Wolff AC, Hammond MEH, Schwartz JN, Hagerty KL, Allred DC, Cote RJ, Dowsett M, Fitzgibbons PL, Hanna WM, Langer A. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med. 2007;131(1):18–43.PubMed

14.

Force UPST. Screening for breast cancer: US preventive services task force recommendation statement. Ann Intern Med. 2009;151(10):716.CrossRef

15.

Vostakolaei FA, Broeders MJ, Rostami N, Van Dijck JA, Feuth T, Kiemeney LA, Verbeek AL. Age at diagnosis and breast cancer survival in Iran. Int J Breast Cancer. 2012;2012:8. https://doi.org/10.1155/2012/517976.

16.

Howlader N, Noone A, Krapcho M, Miller D, Bishop K, Kosary C. SEER Cancer Statistics Review, 1975–2014, based on November 2016 SEER data submission, posted to the SEER web site, April 2017. Bethesda: National Cancer Institute; 2014.

17.

Kim HK, Ham JS, Byeon S, Yoo KH, Jung KS, Song H-N, Cho J, Lee JY, Lim SH, Kim HS. Clinicopathologic features and long-term outcomes of elderly breast cancer patients: experiences at a single institution in Korea. Cancer Res Treat. 2016;48(4):1382.CrossRefPubMedPubMedCentral

18.

Pogoda K, Niwinska A, Murawska M, Pienkowski T. Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients. Med Oncol. 2013;30(1):388. https://doi.org/10.1007/s12032-012-0388-4.CrossRefPubMedPubMedCentral

19.

Harirchi I, Ebrahimi M, Zamani N, Jarvandi S, Montazeri A. Breast cancer in Iran: a review of 903 case records. Public Health. 2000;114(2):143–5.PubMed

Title: Do site and type of metastasis in breast cancer show a changing pattern with increased age? A cross comparison of clinicopathological characteristics between age groups
Authors: Majid Akrami
Afrooz Sepahdar
Peyman Arasteh
Sedigheh Tahmasebi
Vahid Zangouri
Azam Askari
Babak Pezeshki
Abdolrasoul Talei
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: World Journal of Surgical Oncology / Issue 1/2018
Electronic ISSN: 1477-7819
DOI: https://doi.org/10.1186/s12957-018-1435-1

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Do site and type of metastasis in breast cancer show a changing pattern with increased age? A cross comparison of clinicopathological characteristics between age groups

Abstract

Background

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2018

Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients

Introducing novel and comprehensive models for predicting recurrence in breast cancer using the group LASSO approach: are estimates of early and late recurrence different?

Bursectomy for advanced gastric cancer: an update meta-analysis

Case report about a successful full robotic radical gastric cancer surgery with intracorporeal robot-sewn anastomosis in a patient with situs inversus totalis and a two-and-a-half-year follow-up study

Early anal gland adenocarcinoma with a characteristic submucosal tumor-like appearance: a case report

Evaluation of the expression and clinical value of lncRNA AC010761.9 in human gastric adenocarcinoma